Figure S1. TIA1 antibodies demonstrate significant variability. Four commercial TIA1 antibodies were screened for performance in fluorescent immunohistochemical assays: Abcam 40,693 (A), Santa Cruz 1751 (B), Abcam 140,595 (C), and Cell Signaling 1398S (D). Of these, only Abcam 40,693 demonstrated affinity for both cytoplasmic and nuclear TIA1 with minimal background reactivity, but also shows performance variability between lots (E). Figure S2. Co-immunoprecipitation (co-IP) and immunoblotting (IB) of tau and RBPs from the brains of P301S tau mice (n = 2). HNRNPA0 (35kD), eIF4a2 (47kD), HNRNPK (55kd), and RPL11 (23kD) co-IPd with Tau13 (left) but not normal mouse IgG (right). Figure S3. Immunhistochemical analysis of rTg4510 tissue (n = 3) ...
Figure S1. CSF was collected from patients and controls by a lumbar puncture, obtaining about 10 ml ...
Figure S1. Accumulation of soluble, hyperphosphorylated tau in A152T-expressing mice. Figure S2. Inc...
Figure S2. Blocking phospho-peptides abolished epitope recognition by TAOK-pS181, tau-pT123 and tau-...
Table S1. Overview of mutations investigated during the maturation process. Table S2. Names and sequ...
Figure S1. Western blot results of tau expression in mice expressing pro- or anti-aggregant human ta...
Ac-K274 tau inclusions in human tauopathy brains. (A-C) Representative images of ac-K274 tau immunos...
Table S1. Extended demographic data of cases included in the study. Figure S1. Tau immunohistochemis...
Figure S1. Total and phosphorylated soluble tau in hippocampus, cortex and HB. (a, b, c) In the hipp...
Undigested P3 fraction assessed with CP13 and PHF1 antibodies. A schematic of antibody epitopes is p...
Tau pathology observed with the Tau/pS422 antibody. a-f Immunofluorescence staining against hyperpho...
Table S2. List of antibodies used in the study. This table provides source information for each anti...
Additional file 1: Supplementary Table 1. Calculated area under the curves for panels 1B, 1C and 1E....
Online Source 9 Double labeling of pSer262 and pSer202/Thr205 tau in the temporal cortex at Braak st...
Figure S1. Doxycycline-inducible cell line expressing human mutant P301L tau. Western blot of cell l...
T5x mice exhibit increased levels of Tau phosphorylation and misfolding. (A) The ratio of phosphoryl...
Figure S1. CSF was collected from patients and controls by a lumbar puncture, obtaining about 10 ml ...
Figure S1. Accumulation of soluble, hyperphosphorylated tau in A152T-expressing mice. Figure S2. Inc...
Figure S2. Blocking phospho-peptides abolished epitope recognition by TAOK-pS181, tau-pT123 and tau-...
Table S1. Overview of mutations investigated during the maturation process. Table S2. Names and sequ...
Figure S1. Western blot results of tau expression in mice expressing pro- or anti-aggregant human ta...
Ac-K274 tau inclusions in human tauopathy brains. (A-C) Representative images of ac-K274 tau immunos...
Table S1. Extended demographic data of cases included in the study. Figure S1. Tau immunohistochemis...
Figure S1. Total and phosphorylated soluble tau in hippocampus, cortex and HB. (a, b, c) In the hipp...
Undigested P3 fraction assessed with CP13 and PHF1 antibodies. A schematic of antibody epitopes is p...
Tau pathology observed with the Tau/pS422 antibody. a-f Immunofluorescence staining against hyperpho...
Table S2. List of antibodies used in the study. This table provides source information for each anti...
Additional file 1: Supplementary Table 1. Calculated area under the curves for panels 1B, 1C and 1E....
Online Source 9 Double labeling of pSer262 and pSer202/Thr205 tau in the temporal cortex at Braak st...
Figure S1. Doxycycline-inducible cell line expressing human mutant P301L tau. Western blot of cell l...
T5x mice exhibit increased levels of Tau phosphorylation and misfolding. (A) The ratio of phosphoryl...
Figure S1. CSF was collected from patients and controls by a lumbar puncture, obtaining about 10 ml ...
Figure S1. Accumulation of soluble, hyperphosphorylated tau in A152T-expressing mice. Figure S2. Inc...
Figure S2. Blocking phospho-peptides abolished epitope recognition by TAOK-pS181, tau-pT123 and tau-...